ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #5,287Hybrid

American Journal of Cardiovascular Drugs

Acronym:cvda
•
Abbreviation (ISO):AM J CARDIOVASC DRUG
•
Identifier (ISSN):1175-3277(Print)/1179-187X(Online)
•
Publisher:Springer International Publishing
Clarivate IF (2026)
3.2↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for American Journal of Cardiovascular Drugs

WoS Q2
12452.6420182.5820192.6720203.5720213.282022320232.82024320253.22026
Annual Impact Factor Metric
Current (2026):3.2
Scopus SJR & RankScopus Q1
0.952
#5,287

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
66

66 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate3.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
50articles/year
28.49% Gold OA•61.54% Original Research

Aims & Scope

Promoting rational therapy within the discipline of cardiology, the American Journal of Cardiovascular Drugs covers all aspects of the treatment of cardiovascular disorders, particularly the place in therapy of newer and established agents. Via a program of reviews and original clinical research articles, the journal addresses major issues relating to treatment of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of cardiovascular disorders; and the practical management of specific clinical situations. The American Journal of Cardiovascular Drugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Topics Covered (Recognized by AI)
Medicine99.9%Internal medicine98.7%Biology85.1%Psychology65.6%Cardiology64.5%Psychiatry64.2%Chemistry57.6%Pathology56.3%Biochemistry52.2%Endocrinology50.3%Pharmacology45.7%Surgery39.1%Intensive care medicine35.4%Nursing34.9%Pharmacotherapy32%Radiology28.9%Myocardial infarction26.3%Bioinformatics23.7%Physics22.7%Blood pressure21.4%Alternative medicine21.2%Genetics20.5%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Q2
Rank86/237
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank156/356
IndexSCIE
JCISCIE2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Q2
Rank97/237
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank178/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.2
Articles / Year30
Total Citations4
2025
IF3
Articles / Year67
Total Citations177
2024
IF2.8
Articles / Year91
Total Citations507
2023
IF3
Articles / Year62
Total Citations585
2022
IF3.283
Articles / Year42
Total Citations492

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,287Scopus Q1SCImago Profile
Scopus Coverage:2001-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
0.952

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.39

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,261 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations604
3-Year Documents188
Citable Documents174

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate35.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cardiology and Cardiovascular MedicineQ1
Medicine (miscellaneous)Q1
Pharmacology (medical)Q1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区CARDIAC & CARDIOVASCULAR SYSTEMS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

American Journal of Cardiovascular Drugs (acronym: cvda, abbr: AM J CARDIOVASC DRUG, ISSN: 1175-3277) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer International Publishing in New Zealand since 2001. The periodical holds a Journal Impact Factor (JIF) of 3.20, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.952 (Q1), an H-index of 66.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 50 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,261 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer International Publishing
Publication Language
English
Frequency
Bimonthly
Founding Year
2001
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d4244649-f88c-4c68-8b5a-c4c2bbd5fb01
Database Updated: 2026-09-30